CSS
EPIX

Cubist Systematic Strategies’s ESSA Pharma EPIX Stock Holding History

Cubist Systematic Strategies’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,115
Closed -$22.3K – 3113
2025
Q1 		$22.3K Sell
14,115
-12,172
-46% -$20.6K ﹤0.01% 2743
2024
Q4 		$47.1K Buy
+26,287
New +$83.7K ﹤0.01% 2788
2023
Q1 		– Sell
-34,086
Closed -$85.9K – 4027
2022
Q4 		$85.9K Sell
34,086
-21,528
-39% -$61.8K ﹤0.01% 3829
2022
Q3 		$101K Buy
55,614
+25,715
+86% +$67.8K ﹤0.01% 4014
2022
Q2 		$94K Sell
29,899
-12,000
-29% -$67K ﹤0.01% 3987
2022
Q1 		$259K Buy
+41,899
New +$368K ﹤0.01% 2920
2021
Q4 		– Sell
-34,828
Closed -$279K – 3505
2021
Q3 		$279K Buy
+34,828
New +$554K ﹤0.01% 2400

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $133M AUM 42.18% 1-Year Est. Return
DAM
DLD Asset Management New York $1.51B AUM 5.32% 1-Year Est. Return

Cubist Systematic Strategies's EPIX Position: Q2 2025 in Review

Cubist Systematic Strategies sold out of ESSA Pharma (EPIX) in Q2 2025, closing a stake of 14,115 shares — an estimated $22.3K sold.

Cubist Systematic Strategies first reported a position in EPIX in Q3 2021 and held it in 7 quarters. The position peaked at $279K in Q3 2021. 36 funds tracked by Wall St. Rank hold EPIX as of Q2 2025.

  • Cubist Systematic Strategies reported no remaining ESSA Pharma position as of Q2 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 14,115 ESSA Pharma shares in Q2 2025, an estimated $22.3K.
  • Cubist Systematic Strategies first reported a position in ESSA Pharma in Q3 2021 and held it in 7 quarters.
  • Cubist Systematic Strategies's ESSA Pharma position peaked at $279K in Q3 2021.
  • 36 funds tracked by Wall St. Rank held ESSA Pharma as of Q2 2025.

Based on Cubist Systematic Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.